Bridgewater, NJ, United States of America

Harpreet Sandhu


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Harpreet Sandhu: Innovator in Pharmaceutical Formulations

Introduction

Harpreet Sandhu is a notable inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that enhance the stability of active pharmaceutical ingredients. His work is crucial for improving the efficacy and safety of medications.

Latest Patents

Harpreet Sandhu holds a patent for "Formulations, methods, kit, and dosage forms for improved stability of an active pharmaceutical ingredient." This patent focuses on formulations that maintain the active ingredient in a substantially amorphous form after storage under predetermined conditions. The invention is particularly relevant for treating conditions associated with the dysregulation of the RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways. He has 1 patent to his name.

Career Highlights

Harpreet Sandhu is currently associated with Asana Biosciences, LLC, where he continues to innovate in the pharmaceutical sector. His expertise in formulation science has positioned him as a valuable asset in the development of new therapeutic solutions.

Collaborations

Harpreet has collaborated with notable colleagues, including Navnit Hargovindas Shah and Ashish Chatterji. These collaborations have fostered a productive environment for research and development in the pharmaceutical industry.

Conclusion

Harpreet Sandhu's contributions to pharmaceutical formulations demonstrate his commitment to advancing medical science. His innovative work is essential for the development of more effective treatments, showcasing the importance of stability in active pharmaceutical ingredients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…